Apollo, Carlyle, EQT team up with VC firms to tap biotech growth market

'Partnering with a team that is deeply versed in the science like Sofinnova is critical to meaningfully scale and accelerate our investment activity,' said Apollo's Neil Mehta.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this